FIELD: medicine.
SUBSTANCE: invention is intended for the treatment of glaucomatous optic neuropathy with open-angle glaucoma. To investigate the performance of the method of the true intraocular pressure (IOP), the state of visual field characteristic ophthalmoscopic excavation of the optic nerve. With increasing true IOP above 23 mm Hg, narrowing the field of view of the nasal side by 10 degrees and the degree of availability of excavation of the optic nerve 0.3 prescribe vinpocetine in form of tablets, piracetam in the form of dragees and detraleks in tablet form. Drug therapy was carried out for 3 months.
EFFECT: use of the method provides a combined effect of all the main components of glaucomatous optic neuropathy, as well as compensation of intraocular pressure and stabilization of visual function.
1 cl, 1 dwg, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR MACULAR AREA MORPHOMETRIC CHANGES TREATMENT IN CASE OF POLYMORBIDE SOMATIC CONDITIONS | 2016 |
|
RU2622759C1 |
METHOD FOR COMPLEX TREATMENT OF HEMODYNAMIC DISORDERS OF BULBAR CONJUNCTIVA OF PATIENTS WITH COVID-19 ASSOCIATED PNEUMONIA | 2021 |
|
RU2747408C1 |
METHOD FOR THE ETIOPATHOGENETIC TREATMENT OF PARAVASAL DISORDERS OF BULBAR CONJUNCTIVA IN PATIENTS WITH COVID-19 ASSOCIATED PNEUMONIA | 2021 |
|
RU2760297C1 |
METHOD FOR COMBINED TREATMENT OF GLAUCOMATOUS OPTIC NEUROPATHY | 2015 |
|
RU2576785C1 |
METHOD FOR CORRECTION OF HEMODYNAMIC ABNORMALITIES IN CASE OF VASCULAR PATHOLOGY OF VISUAL NERVE | 2009 |
|
RU2405410C1 |
METHOD OF COMBINED TREATMENT OF GLAUCOMATOUS OPTIC NEUROPATHY | 2010 |
|
RU2472475C2 |
IMPLANT FOR POSTERIOR POLE REVASCULARISATION IN PATIENTS WITH GLAUCOMA | 2014 |
|
RU2557915C1 |
METHOD FOR TREATMENT OF GLAUCOMA OPTICAL NEUROPATHY | 2005 |
|
RU2284192C1 |
METHOD OF TREATING GLAUCOMATOUS OPTIC NEUROPATHY | 2013 |
|
RU2546019C2 |
METHOD OF TREATMENT OF GLAUCOMA OPTIC NEUROPATHY | 2023 |
|
RU2813156C1 |
Authors
Dates
2016-03-27—Published
2015-04-06—Filed